Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

buprenorphine-nalOXone

buprenorphine-nalOXone
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Bunavail FILM, BUCCAL 2.1 mg-0.3 mg, 4.2 mg-0.7 mg, 6.3 mg-1 mg    
Suboxone FILM, SUBLINGUAL 2 mg-0.5 mg, 4 mg-1 mg, 8 mg-2 mg, 12 mg-3 mg    
Zubsolv TABLET, SUBLINGUAL 1.4 mg-0.36 mg, 5.7 mg-1.4 mg    
Suboxone TABLET, SUBLINGUAL 2 mg-0.5 mg, 8 mg-2 mg      


Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

buprenorphine-nalOXone (Bunavail)

  • 2.1 mg-0.3 mg film buccal                            
  • 4.2 mg-0.7 mg film buccal
  • 6.3 mg-1 mg film buccal                                                                                   
  • TWO 6.3 mg-1 mg film buccal (Total: 12.6 mg-2.1 mg)

buprenorphine-nalOXone (Suboxone)

  • TWO 2 mg-0.5 tablets  (Total: 4 mg- 1 mg)
  • 8 mg-2 mg tablet
  • ONE 8 mg-2mg tablet PLUS TWO 2 mg-0.5 mg tablets (Total: 12 mg- 3 mg)
  • THREE 8 mg-2 mg tablets (Total: 24 mg-6 mg)

buprenorphine-nalOXone (Suboxone)

  • 2 mg-0.5 mg film sublingual
  • 4 mg-1 mg film sublingual                            
  • 8 mg-2 mg film sublingual
  • 12 mg-3 mg film sublingual

buprenorphine-nalOXone (Suboxone)

  • 2 mg-0.5 mg tablet 
  • TWO 2 mg-0.5 mg tablets (Total: 4 mg-1 mg)
  • 8 mg-2 mg tablet 
  • ONE 8 mg-2 mg tablet PLUS TWO 2 mg-0.5 mg tablets (Total: 12 mg-3 mg)

 buprenorphine-nalOXone (Zubsolv)

  • 1.4 mg-0.36 mg tablet sublingual
  • 5.7 mg-1.4 mg tablet sublingual

buprenorphine-nalOXone (Suboxone)

  • 2 mg-0.5 mg tablet 
  • 8 mg-2 mg tablet 

Bunavail medication guide

Suboxone sublingual tablets medication guide

Zubsolv medication guide


Reviewed: April 22, 2008 and November 16, 2010 (SUBOXONE sublingual film) and April 28, 2015 (BUNAVAIL)


REMS (Bunavail, Zubsolv, buprenorphine-nalOXone) : Buprenorphine Transmucosal Products for Opioid Dependence (BTOD)

REMS: Suboxone/Subutex (buprenorphine and nalOXone/buprenorphine)


Last updated: Oct. 27, 2023







This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.